Logo

Armin Winands and Jan Hellemans

Jul 03, 2018

Belgian genomics service provider Biogazelle has appointed Armin Winands as its new CEO. Winands most recently served as director of business development at ArcherDX. Over the past 23 years, he has also held senior sales positions at NuGEN Technologies, Ingenuity Systems, Ion Torrent Systems, Illumina, Affymetrix, and Molecular Dynamics. Winands replaces Jan Hellemans, who served as CEO of Biogazelle for the past 10 years and will now take on the role of chief technology officer.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.